256 related articles for article (PubMed ID: 10196215)
1. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain.
Netzer KO; Leinonen A; Boutaud A; Borza DB; Todd P; Gunwar S; Langeveld JP; Hudson BG
J Biol Chem; 1999 Apr; 274(16):11267-74. PubMed ID: 10196215
[TBL] [Abstract][Full Text] [Related]
2. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
[TBL] [Abstract][Full Text] [Related]
3. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease.
Hellmark T; Segelmark M; Unger C; Burkhardt H; Saus J; Wieslander J
Kidney Int; 1999 Mar; 55(3):936-44. PubMed ID: 10027930
[TBL] [Abstract][Full Text] [Related]
4. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope.
David M; Borza DB; Leinonen A; Belmont JM; Hudson BG
J Biol Chem; 2001 Mar; 276(9):6370-7. PubMed ID: 11098057
[TBL] [Abstract][Full Text] [Related]
6. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
Kalluri R; Sun MJ; Hudson BG; Neilson EG
J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
[TBL] [Abstract][Full Text] [Related]
7. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
[TBL] [Abstract][Full Text] [Related]
9. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.
Chen L; Hellmark T; Wieslander J; Bolton WK
Kidney Int; 2003 Dec; 64(6):2108-20. PubMed ID: 14633133
[TBL] [Abstract][Full Text] [Related]
10. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.
Hellmark T; Burkhardt H; Wieslander J
J Biol Chem; 1999 Sep; 274(36):25862-8. PubMed ID: 10464328
[TBL] [Abstract][Full Text] [Related]
11. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
12. Precise mapping of the Goodpasture epitope(s) using phage display, site-directed mutagenesis, and surface plasmon resonance.
Gozalbo-Rovira R; Rodríguez-Díaz J; Saus J; Cervera J
Kidney Int; 2013 Mar; 83(3):438-45. PubMed ID: 23254898
[TBL] [Abstract][Full Text] [Related]
13. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
[TBL] [Abstract][Full Text] [Related]
14. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of the 'Goodpasture antigen' of mammals.
Ryan JJ; Katbamna I; Mason PJ; Pusey CD; Turner AN
Nephrol Dial Transplant; 1998 Mar; 13(3):602-7. PubMed ID: 9550634
[TBL] [Abstract][Full Text] [Related]
16. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
17. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen.
Neilson EG; Kalluri R; Sun MJ; Gunwar S; Danoff T; Mariyama M; Myers JC; Reeders ST; Hudson BG
J Biol Chem; 1993 Apr; 268(12):8402-5. PubMed ID: 8473281
[TBL] [Abstract][Full Text] [Related]
18. Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.
Hellmark T; Chen L; Ohlsson S; Wieslander J; Bolton WK
J Biol Chem; 2003 Nov; 278(47):46516-22. PubMed ID: 12970356
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
20. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]